125 related articles for article (PubMed ID: 23919738)
1. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors.
Rydén A; Denison H; Karlsson M; Vakil N
Scand J Gastroenterol; 2013 Sep; 48(9):1018-26. PubMed ID: 23919738
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy.
Rydén A; Leavy OC; Halling K; Stone AA
Value Health; 2016; 19(6):829-833. PubMed ID: 27712711
[TBL] [Abstract][Full Text] [Related]
3. PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
Fuller G; Bolus R; Whitman C; Talley J; Erder MH; Joseph A; Silberg DG; Spiegel B
Dig Dis Sci; 2017 Mar; 62(3):593-606. PubMed ID: 28116591
[TBL] [Abstract][Full Text] [Related]
4. Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy.
Vakil N; Björck K; Denison H; Halling K; Karlsson M; Paty J; Silberg DG; Rydén A
Clin Transl Gastroenterol; 2012 Jan; 3(1):e7. PubMed ID: 23238029
[TBL] [Abstract][Full Text] [Related]
5. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.
Mönnikes H; Bardhan KD; Stanghellini V; Berghöfer P; Bethke TD; Armstrong D
Digestion; 2007; 75 Suppl 1():41-7. PubMed ID: 17489031
[TBL] [Abstract][Full Text] [Related]
7. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
Bardhan KD; Berghöfer P
Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
[TBL] [Abstract][Full Text] [Related]
8. Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.
Vakil N; Niklasson A; Denison H; Rydén A
BMC Gastroenterol; 2014 Oct; 14():177. PubMed ID: 25304129
[TBL] [Abstract][Full Text] [Related]
9. Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure.
Bytzer P; Reimer C; Smith G; Anatchkova MD; Hsieh R; Wilkinson J; Thomas SJ; Lenderking WR
Scand J Gastroenterol; 2017 Mar; 52(3):276-283. PubMed ID: 27826993
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and Validation of the Modified Reflux Symptom Questionnaire-Electronic Diary in Patients With Persistent Gastroesophageal Reflux Disease.
Andrae DA; Hanlon J; Cala ML; Scippa K; Graham C; Witherspoon B; Shao JZ; Reasner D
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00117. PubMed ID: 31977454
[TBL] [Abstract][Full Text] [Related]
11. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
Kahrilas PJ; Howden CW; Hughes N
Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease.
Vakil N; Niklasson A; Denison H; Rydén A
United European Gastroenterol J; 2015 Oct; 3(5):443-52. PubMed ID: 26535123
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
15. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.
Dore MP; Pedroni A; Pes GM; Maragkoudakis E; Tadeu V; Pirina P; Realdi G; Delitala G; Malaty HM
Dig Dis Sci; 2007 Feb; 52(2):463-8. PubMed ID: 17211695
[TBL] [Abstract][Full Text] [Related]
16. Antireflux surgery in the proton pump inhibitor era.
Bulsiewicz WJ; Madanick RD
Cleve Clin J Med; 2012 Apr; 79(4):273-81. PubMed ID: 22473727
[TBL] [Abstract][Full Text] [Related]
17. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
18. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
[TBL] [Abstract][Full Text] [Related]
19. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
20. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.
Goh KL; Choi MG; Hsu WP; Chun HJ; Mahachai V; Kachintorn U; Leelakusolvong S; Kim N; Rani AA; Wong BC; Wu J; Chiu CT; Chu R; Shetty V; Bocobo JC; Chan MM; Lin JT
J Gastroenterol Hepatol; 2014 Dec; 29(12):1969-75. PubMed ID: 24990817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
